Tassey Kenneth A. Jr 4
4 · Boston Therapeutics, Inc. · Filed Mar 27, 2012
Insider Transaction Report
Form 4
Tassey Kenneth A. Jr
DirectorPresident, COO10% Owner
Transactions
- Sale
Common Stock
2012-03-23$0.25/sh−160,000$40,000→ 3,040,000 total
4 · Boston Therapeutics, Inc. · Filed Mar 27, 2012
Common Stock